Cresco Labs Inc.
CRLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.28 | -0.23 | -0.02 | 0.31 |
| FCF Yield | -0.30% | -2.45% | 9.23% | 8.15% |
| EV / EBITDA | 50.68 | 21.72 | 25.28 | 25.32 |
| Quality | ||||
| ROIC | 1.48% | -6.44% | 1.06% | 0.22% |
| Gross Margin | 48.12% | 50.88% | 47.44% | 47.32% |
| Cash Conversion Ratio | -0.28 | -0.64 | -2.00 | 67.17 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.94% | -5.25% | -5.10% | -5.08% |
| Free Cash Flow Growth | 68.78% | -119.06% | -9.89% | -39.62% |
| Safety | ||||
| Net Debt / EBITDA | 26.94 | 15.79 | 16.65 | 15.48 |
| Interest Coverage | 1.17 | 1.16 | 0.87 | 1.41 |
| Efficiency | ||||
| Inventory Turnover | 0.92 | 0.90 | 1.00 | 1.10 |
| Cash Conversion Cycle | 102.64 | 102.56 | 95.35 | 94.82 |